@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GCSXQJV2-S
  skos:altLabel "Famille des molécules de signalisation de l'activation lymphocytaire"@fr, "Récepteurs de la famille SLAM"@fr, "Signaling Lymphocytic Activation Molecules"@en, "SLAM Family Receptors"@en, "Récepteurs SLAMF"@fr, "Signaling Lymphocytic Activation Molecule Receptors"@en, "Molécules de signalisation de l'activation des lymphocytes"@fr, "SLAMF Receptors"@en, "Récepteurs de signalisation de l'activation des lymphocytes"@fr, "Récepteurs de signalisation de l'activation lymphocytaire"@fr, "Famille des récepteurs de signalisation de l'activation des lymphocytes"@fr, "Famille des récepteurs de signalisation de l'activation lymphocytaire"@fr, "Molécules de signalisation de l'activation lymphocytaire"@fr, "Signaling Lymphocytic Activation Molecule Family Receptors"@en ;
  skos:broader jvr:-GLFGW4X8-S, jvr:-MTK0PBMF-D ;
  skos:definition "Type-I membrane glycoproteins that are expressed primarily on the surface of CD4 or CD8-positive T-CELLS; NATURAL KILLER CELLS; and some populations of B CELLS. They are characterized by an N-terminal, extracellular IMMUNOGLOBULIN-LIKE DOMAIN and a membrane-proximal IMMUNOGLOBULIN C2-SET DOMAIN. SLAMF receptors typically signal through homophilic interactions and are important for mediating the immune response and immune cell differentiation."@en ;
  skos:prefLabel "Famille des molécules de signalisation de l'activation des lymphocytes"@fr, "Signaling Lymphocytic Activation Molecule Family"@en ;
  mesh:allowableQualifier jvr:-Q3979798-W, jvr:-WZF2ZR3L-B, jvr:-G7KXQWSR-5, jvr:-S0CS1X5R-5, jvr:-H7K65Q8S-Z, jvr:-Z9TSGBXH-4, jvr:-W6SQV79N-S, jvr:-HQRFT0C6-B, jvr:-T2TS0S41-N, jvr:-TJHVZCRZ-0, jvr:-SBNWSM1T-R, jvr:-CJXMKG5Q-F, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-D0F21513-5, jvr:-M63HSDM7-1, jvr:-R0ZCQ8X6-J, jvr:-N2WP45CN-V, jvr:-L6C0XPHT-4 ;
  skos:inScheme jvr: ;
  dc:created "2016-07-08"^^xsd:date ;
  dc:established "2017-01-01"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  skos:narrower jvr:-NQ8T6PQJ-V, jvr:-SZLV9S8M-7 ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000071176> ;
  dc:modified "2017-05-24"^^xsd:date .

jvr:-MTK0PBMF-D
  skos:prefLabel "Glycoprotéines membranaires"@fr, "Membrane Glycoproteins"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-GCSXQJV2-S .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SZLV9S8M-7
  skos:prefLabel "Signaling Lymphocytic Activation Molecule Family Member 1"@en, "Membre-1 de la famille des molécules de signalisation de l'activation des lymphocytes"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-GCSXQJV2-S .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GLFGW4X8-S
  skos:prefLabel "Récepteurs immunologiques"@fr, "Receptors, Immunologic"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-GCSXQJV2-S .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NQ8T6PQJ-V
  skos:prefLabel "CD48 Antigen"@en, "Antigène CD48"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-GCSXQJV2-S .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CJXMKG5Q-F
  skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

